Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
147
Frequently Asked Questions
What is Market Cap of Caribou Biosciences Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Caribou Biosciences Inc market cap is $167.62M.
What is the 52-week high for Caribou Biosciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Caribou Biosciences Inc 52 week high is $3.00 as of September 15, 2025.
What is the 52-week low for Caribou Biosciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Caribou Biosciences Inc 52 week low is $0.66 as of September 15, 2025.
What is Caribou Biosciences Inc stock price today?
Caribou Biosciences Inc stock price today is $1.82.
What was Caribou Biosciences Inc stock price yesterday?
Caribou Biosciences Inc stock price yesterday was $1.80.
What is the PE ratio of Caribou Biosciences Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Caribou Biosciences Inc’s P/E ratio is -1.01.
What is the Price-to-Book ratio of Caribou Biosciences Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Caribou Biosciences Inc P/B ratio is 1.0090.
What is the 50-day moving average of Caribou Biosciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Caribou Biosciences Inc 50-day moving average is $1.90.
How many employess does Caribou Biosciences Inc has?
